tiprankstipranks
Trending News
More News >
Eli Lilly & Co (DE:LLY)
XETRA:LLY
Germany Market
Advertisement

Eli Lilly & Co (LLY) Stock Forecast & Price Target

Compare
161 Followers
See the Price Targets and Ratings of:

LLY Analyst Ratings

Strong Buy
19Ratings
Strong Buy
16 Buy
2 Hold
1 Sell
Based on 19 analysts giving stock ratings to
Eli
Lilly & Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LLY Stock 12 Month Forecast

Average Price Target

€857.32
▲(25.52%Upside)
Based on 19 Wall Street analysts offering 12 month price targets for Eli Lilly & Co in the last 3 months. The average price target is €857.32 with a high forecast of €1,013.32 and a low forecast of €596.07. The average price target represents a 25.52% change from the last price of €683.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"595":"€595","1014":"€1,014","699.75":"€699.8","804.5":"€804.5","909.25":"€909.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1013.3213426,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€1.01K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":857.320947672,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€857.32</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":596.071378,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€596.07</span>\n  </div></div>","useHTML":true}}],"tickPositions":[595,699.75,804.5,909.25,1014],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,668.1,694.6554878923077,721.2109757846154,747.7664636769231,774.3219515692308,800.8774394615384,827.4329273538461,853.9884152461539,880.5439031384615,907.0993910307692,933.6548789230769,960.2103668153845,986.7658547076923,{"y":1013.3213426,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,668.1,682.6554575132308,697.2109150264615,711.7663725396924,726.3218300529231,740.8772875661539,755.4327450793846,769.9882025926154,784.5436601058461,799.0991176190769,813.6545751323076,828.2100326455385,842.7654901587692,{"y":857.320947672,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,668.1,662.5593367692308,657.0186735384616,651.4780103076923,645.9373470769231,640.3966838461539,634.8560206153846,629.3153573846154,623.7746941538461,618.234030923077,612.6933676923077,607.1527044615384,601.6120412307693,{"y":596.071378,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":848.001,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 61,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":763.479,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 71,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":861.223,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 67,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":795.977,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 73,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":756.989,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 55,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":758.724,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":740.792,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":786.917,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 62,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":863.899,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 64,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":755.525,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 62,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":787.059,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 63,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":650,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 73,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":668.1,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 64,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€1,013Average Price Target€857.32Lowest Price Target€596.07
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BMO Capital Analyst forecast on DE:LLY
Evan SeigermanBMO Capital
BMO Capital
€649.02€766.38
Buy
12.21%
Upside
Reiterated
07/22/25
BMO Capital Remains a Buy on Eli Lilly & Co (LLY)
Citi
€1,013.32
Buy
48.36%
Upside
Reiterated
07/21/25
Eli Lilly & Co (LLY) Receives a Buy from Citi
Leerink Partners Analyst forecast on DE:LLY
David RisingerLeerink Partners
Leerink Partners
Buy
Reiterated
07/20/25
Eli Lilly's Strategic Advantage in GLP-1RAs and Alzheimer's Markets Fuels Buy Rating
Jefferies Analyst forecast on DE:LLY
Akash TewariJefferies
Jefferies
€900.07
Buy
31.78%
Upside
Reiterated
07/18/25
Jefferies Remains a Buy on Eli Lilly & Co (LLY)
Guggenheim
€797.03€802.14
Buy
17.44%
Upside
Reiterated
07/11/25
Guggenheim Sticks to Their Buy Rating for Eli Lilly & Co (LLY)
Wells Fargo Analyst forecast on DE:LLY
Mohit BansalWells Fargo
Wells Fargo
€936.68
Buy
37.14%
Upside
Reiterated
07/11/25
Positive Outlook for Eli Lilly & Co Driven by Strong Product Performance and International Growth
Morgan Stanley Analyst forecast on DE:LLY
Terence FlynnMorgan Stanley
Morgan Stanley
€964.78€966.49
Buy
41.51%
Upside
Reiterated
07/10/25
Eli Lilly price target raised to $1,135 from $1,133 at Morgan StanleyEli Lilly price target raised to $1,135 from $1,133 at Morgan Stanley
Bank of America Securities Analyst forecast on DE:LLY
Tim AndersonBank of America Securities
Bank of America Securities
€851.53
Buy
24.68%
Upside
Reiterated
07/09/25
Eli Lilly & Co: Strong Growth Potential and Strategic Market Positioning Justify Buy Rating
Bernstein
€936.68
Buy
37.14%
Upside
Reiterated
07/08/25
Bernstein Keeps Their Buy Rating on Eli Lilly & Co (LLY)
J.P. Morgan Analyst forecast on DE:LLY
Chris SchottJ.P. Morgan
J.P. Morgan
€936.68
Buy
37.14%
Upside
Reiterated
07/07/25
Eli Lilly & Co: Strong Growth Potential and Strategic Positioning Justify Buy Rating
UBS
€894.11
Buy
30.91%
Upside
Reiterated
06/27/25
UBS Sticks to Their Buy Rating for Eli Lilly & Co (LLY)
TD Cowen Analyst forecast on DE:LLY
Steve ScalaTD Cowen
TD Cowen
€817.47
Buy
19.69%
Upside
Reiterated
06/25/25
TD Cowen Remains a Buy on Eli Lilly & Co (LLY)
Evercore ISI Analyst forecast on DE:LLY
Umer RaffatEvercore ISI
Evercore ISI
Hold
Reiterated
06/23/25
Evercore ISI Sticks to Its Hold Rating for Eli Lilly & Co (LLY)
Goldman Sachs Analyst forecast on DE:LLY
Asad HaiderGoldman Sachs
Goldman Sachs
€751.9
Buy
10.09%
Upside
Reiterated
06/23/25
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY) and Sana Biotechnology (NASDAQ: SANA)
Truist Financial Analyst forecast on DE:LLY
Srikripa DevarakondaTruist Financial
Truist Financial
Buy
Reiterated
06/23/25
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY), Exelixis (NASDAQ: EXEL) and Abbott Laboratories (NYSE: ABT)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BMO Capital Analyst forecast on DE:LLY
Evan SeigermanBMO Capital
BMO Capital
€649.02€766.38
Buy
12.21%
Upside
Reiterated
07/22/25
BMO Capital Remains a Buy on Eli Lilly & Co (LLY)
Citi
€1,013.32
Buy
48.36%
Upside
Reiterated
07/21/25
Eli Lilly & Co (LLY) Receives a Buy from Citi
Leerink Partners Analyst forecast on DE:LLY
David RisingerLeerink Partners
Leerink Partners
Buy
Reiterated
07/20/25
Eli Lilly's Strategic Advantage in GLP-1RAs and Alzheimer's Markets Fuels Buy Rating
Jefferies Analyst forecast on DE:LLY
Akash TewariJefferies
Jefferies
€900.07
Buy
31.78%
Upside
Reiterated
07/18/25
Jefferies Remains a Buy on Eli Lilly & Co (LLY)
Guggenheim
€797.03€802.14
Buy
17.44%
Upside
Reiterated
07/11/25
Guggenheim Sticks to Their Buy Rating for Eli Lilly & Co (LLY)
Wells Fargo Analyst forecast on DE:LLY
Mohit BansalWells Fargo
Wells Fargo
€936.68
Buy
37.14%
Upside
Reiterated
07/11/25
Positive Outlook for Eli Lilly & Co Driven by Strong Product Performance and International Growth
Morgan Stanley Analyst forecast on DE:LLY
Terence FlynnMorgan Stanley
Morgan Stanley
€964.78€966.49
Buy
41.51%
Upside
Reiterated
07/10/25
Eli Lilly price target raised to $1,135 from $1,133 at Morgan StanleyEli Lilly price target raised to $1,135 from $1,133 at Morgan Stanley
Bank of America Securities Analyst forecast on DE:LLY
Tim AndersonBank of America Securities
Bank of America Securities
€851.53
Buy
24.68%
Upside
Reiterated
07/09/25
Eli Lilly & Co: Strong Growth Potential and Strategic Market Positioning Justify Buy Rating
Bernstein
€936.68
Buy
37.14%
Upside
Reiterated
07/08/25
Bernstein Keeps Their Buy Rating on Eli Lilly & Co (LLY)
J.P. Morgan Analyst forecast on DE:LLY
Chris SchottJ.P. Morgan
J.P. Morgan
€936.68
Buy
37.14%
Upside
Reiterated
07/07/25
Eli Lilly & Co: Strong Growth Potential and Strategic Positioning Justify Buy Rating
UBS
€894.11
Buy
30.91%
Upside
Reiterated
06/27/25
UBS Sticks to Their Buy Rating for Eli Lilly & Co (LLY)
TD Cowen Analyst forecast on DE:LLY
Steve ScalaTD Cowen
TD Cowen
€817.47
Buy
19.69%
Upside
Reiterated
06/25/25
TD Cowen Remains a Buy on Eli Lilly & Co (LLY)
Evercore ISI Analyst forecast on DE:LLY
Umer RaffatEvercore ISI
Evercore ISI
Hold
Reiterated
06/23/25
Evercore ISI Sticks to Its Hold Rating for Eli Lilly & Co (LLY)
Goldman Sachs Analyst forecast on DE:LLY
Asad HaiderGoldman Sachs
Goldman Sachs
€751.9
Buy
10.09%
Upside
Reiterated
06/23/25
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY) and Sana Biotechnology (NASDAQ: SANA)
Truist Financial Analyst forecast on DE:LLY
Srikripa DevarakondaTruist Financial
Truist Financial
Buy
Reiterated
06/23/25
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY), Exelixis (NASDAQ: EXEL) and Abbott Laboratories (NYSE: ABT)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Eli Lilly & Co

1 Month
xxx
Success Rate
30/40 ratings generated profit
75%
Average Return
+4.68%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 75.00% of your transactions generating a profit, with an average return of +4.68% per trade.
3 Months
xxx
Success Rate
34/44 ratings generated profit
77%
Average Return
+9.03%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 77.27% of your transactions generating a profit, with an average return of +9.03% per trade.
1 Year
Success Rate
38/42 ratings generated profit
90%
Average Return
+34.40%
reiterated a buy rating 5 days ago
Copying Geoff Meacham's trades and holding each position for 1 Year would result in 90.48% of your transactions generating a profit, with an average return of +34.40% per trade.
2 Years
xxx
Success Rate
30/32 ratings generated profit
94%
Average Return
+29.40%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 93.75% of your transactions generating a profit, with an average return of +29.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LLY Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
1
1
4
8
8
Buy
63
61
59
65
56
Hold
2
0
1
3
6
Sell
0
1
1
1
0
Strong Sell
0
0
0
0
0
total
66
63
65
77
70
In the current month, LLY has received 64 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. LLY average Analyst price target in the past 3 months is 857.32.
Each month's total comprises the sum of three months' worth of ratings.

LLY Financial Forecast

LLY Earnings Forecast

Next quarter’s earnings estimate for LLY is €4.76 with a range of €4.49 to €5.04. The previous quarter’s EPS was €2.84. LLY beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.99% of the time in the same period. In the last calendar year LLY has Outperformed its overall industry.
Next quarter’s earnings estimate for LLY is €4.76 with a range of €4.49 to €5.04. The previous quarter’s EPS was €2.84. LLY beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.99% of the time in the same period. In the last calendar year LLY has Outperformed its overall industry.

LLY Sales Forecast

Next quarter’s sales forecast for LLY is €12.51B with a range of €12.26B to €12.76B. The previous quarter’s sales results were €10.84B. LLY beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.43% of the time in the same period. In the last calendar year LLY has Outperformed its overall industry.
Next quarter’s sales forecast for LLY is €12.51B with a range of €12.26B to €12.76B. The previous quarter’s sales results were €10.84B. LLY beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.43% of the time in the same period. In the last calendar year LLY has Outperformed its overall industry.

LLY Stock Forecast FAQ

What is DE:LLY’s average 12-month price target, according to analysts?
Based on analyst ratings, Eli Lilly & Co’s 12-month average price target is 857.32.
    What is DE:LLY’s upside potential, based on the analysts’ average price target?
    Eli Lilly & Co has 25.52% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Eli Lilly & Co a Buy, Sell or Hold?
          Eli Lilly & Co has a consensus rating of Strong Buy, which is based on 16 buy ratings, 2 hold ratings and 1 sell ratings.
            What is Eli Lilly & Co’s share price target?
            The average share price target for Eli Lilly & Co is 857.32. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €1,013.32 ,and the lowest forecast is €596.07. The average share price target represents 25.52% Increase from the current price of €683.
              What do analysts say about Eli Lilly & Co?
              Eli Lilly & Co’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.
                How can I buy shares of Eli Lilly & Co?
                To buy shares of DE:LLY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis